Literature DB >> 1592538

SOD2: a new type of tumor-suppressor gene?

A Bravard1, L Sabatier, F Hoffschir, M Ricoul, C Luccioni, B Dutrillaux.   

Abstract

The activity of superoxide dismutases (SOD) 1 and 2 was analysed in correlation with mRNA and chromosome content in 6 SV40-transformed (TF) and in non-transformed (NF) human fibroblast cell lines. Total SOD activity was fairly constant, whereas the ratio SOD2/SOD1 was much lower in TF than in NF. The decrease in SOD2 activity was correlated with a low mRNA content, and with the presence of various chromosomal rearrangements leading to deletions of the long arm of chromosome 6 where the gene is mapped. In contrast, chromosome 21, carrying the gene for SOD1, was not found to be deficient and the SOD1 activity was high. This shows that in TF, the activity of SOD2 is largely determined by gene dosage. It has been proposed that SOD activity could be inversely correlated with cell proliferation, and that SOD2 activity, in particular, was related to cell differentiation. Thus, there is a cascade of events occurring in cell transformation, involving gene deregulation, chromosome (gene) deletion, low mRNA and protein content, low enzyme activity, and acquisition of growth advantage which makes the SOD2 gene a possible new type of tumor-suppressor gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592538     DOI: 10.1002/ijc.2910510323

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.

Authors:  Stephen L Archer; Glenn Marsboom; Gene H Kim; Hannah J Zhang; Peter T Toth; Eric C Svensson; Jason R B Dyck; Mardi Gomberg-Maitland; Bernard Thébaud; Aliya N Husain; Nicole Cipriani; Jalees Rehman
Journal:  Circulation       Date:  2010-06-07       Impact factor: 29.690

2.  Mitochondrial Superoxide Dismutase Has a Protumorigenic Role in Ovarian Clear Cell Carcinoma.

Authors:  L P Madhubhani P Hemachandra; Dong-Hui Shin; Usawadee Dier; James N Iuliano; Sarah A Engelberth; Larissa M Uusitalo; Susan K Murphy; Nadine Hempel
Journal:  Cancer Res       Date:  2015-09-10       Impact factor: 12.701

3.  A recombinant trans-membrane protein hMnSOD-R9 inhibits the proliferation of cervical cancer cells in vitro.

Authors:  Zide Zhang; Luyuan Huang; Qiuhong Wu; Enze Yang; Guang Zhang; Hanxiao Sun; Feng Wang
Journal:  Mol Cell Biochem       Date:  2014-01       Impact factor: 3.396

4.  Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts.

Authors:  Casey Trimmer; Federica Sotgia; Diana Whitaker-Menezes; Renee M Balliet; Gregory Eaton; Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Anthony Howell; Renato V Iozzo; Richard G Pestell; Philipp E Scherer; Franco Capozza; Michael P Lisanti
Journal:  Cancer Biol Ther       Date:  2011-02-15       Impact factor: 4.742

5.  Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells.

Authors:  Yong Xu; Fang Fang; Sanjit K Dhar; Antonio Bosch; William H St Clair; Edward J Kasarskis; Daret K St Clair
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

6.  Immunogold analysis of antioxidant enzymes in human renal cell carcinoma.

Authors:  T D Oberley; J M Sempf; M J Oberley; M L McCormick; K E Muse; L W Oberley
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.

Authors:  S L Church; J W Grant; L A Ridnour; L W Oberley; P E Swanson; P S Meltzer; J M Trent
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

8.  Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma.

Authors:  Alan Prem Kumar; Ser Yue Loo; Sung Won Shin; Tuan Zea Tan; Chon Boon Eng; Rajeev Singh; Thomas Choudary Putti; Chee Wee Ong; Manuel Salto-Tellez; Boon Cher Goh; Joo In Park; Jean Paul Thiery; Shazib Pervaiz; Marie Veronique Clement
Journal:  Antioxid Redox Signal       Date:  2013-11-14       Impact factor: 8.401

Review 9.  Role of nitroso radicals as drug targets in circulatory shock.

Authors:  Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Br J Pharmacol       Date:  2009-06       Impact factor: 8.739

10.  Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells.

Authors:  Michael J Hitchler; Larry W Oberley; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2008-09-18       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.